Tay-Sachs Disease: Infantile vs Late-Onset Symptoms, Genetics, and Carrier Screening

Genetic Basis

Autosomal recessive; mutations in HEXA gene (15q23-q24) → deficiency of β-hexosaminidase A (HexA) → accumulation of GM2 ganglioside in lysosomes, especially neurons.

Infantile (Classic) Tay-Sachs — Onset 3-6 Months

  • Normal development until ~6 months.
  • Cherry-red spot on macula (pathognomonic).
  • Progressive neurodegeneration: hypotonia → hypertonia, spasticity.
  • Developmental regression: loss of motor skills, speech, vision, hearing.
  • Macrocephaly (increased head circumference).
  • Seizures, dysphagia, respiratory failure.
  • Death by age 4-5 years (rarely later).

Juvenile (Subacute) Onset — 2-10 Years

  • Ataxia, dysarthria, spasticity, cognitive decline.
  • Death in adolescence/early adulthood.

Late-Onset (Adult/Chronic) Tay-Sachs — Adolescence to Adulthood

  • Progressive proximal muscle weakness, atrophy (motor neuronopathy).
  • Dysarthria, dysphagia.
  • Psychiatric symptoms (psychosis, depression).
  • Variable progression; lifespan may be near normal.
  • Residual HexA activity (2-10%) modifies severity.

Carrier Screening and Prevention

  • High carrier frequency: Ashkenazi Jewish (1/27), French Canadian, Cajun, Irish American.
  • Screening: HexA enzyme assay + HEXA molecular analysis.
  • Preconception/prenatal counseling; options: IVF+PGD, prenatal diagnosis (CVS/amnio), donor gametes.

Illness - Related Articles